Ubs Group Ag Biomarin Pharmaceutical Inc Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,694,014 shares of BMRN stock, worth $98.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,694,014

Previous 7,500 22486.85%

Holding current value

$98.5 Million

Previous $492,000 24239.23%

% of portfolio

0.02%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$61.25 - $72.83 $11.4 Million - $13.5 Million	185,381 Added 12.29%	1,694,014 $120 Million
Q4 2024 Feb 14, 2025	BUY	$61.93 - $70.49 $40 Million - $45.6 Million	646,662 Added 75.02%	1,508,633 $99.2 Million
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $32.9 Million - $44.7 Million	476,429 Added 123.57%	861,971 $60.6 Million
Q2 2024 Aug 13, 2024	SELL	$74.43 - $92.22 $348 Million - $431 Million	-4,670,897 Reduced 92.38%	385,542 $31.7 Million
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $416 Million - $491 Million	4,963,987 Added 5369.26%	5,056,439 $442 Million
Q4 2023 Feb 09, 2024	SELL	$76.22 - $98.51 $11.6 Million - $15.1 Million	-152,805 Reduced 62.3%	92,452 $8.91 Million
Q3 2023 Nov 09, 2023	SELL	$85.07 - $94.48 $2.1 Million - $2.34 Million	-24,719 Reduced 9.16%	245,257 $21.7 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $6.45 Million - $7.47 Million	74,431 Added 38.06%	269,976 $23.4 Million
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $41.4 Million - $55.3 Million	-471,739 Reduced 70.7%	195,545 $19 Million
Q4 2022 Feb 08, 2023	SELL	$80.93 - $108.63 $35.4 Million - $47.6 Million	-437,947 Reduced 39.62%	667,284 $69.1 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $130 Million - $154 Million	-1,588,293 Reduced 58.97%	1,105,231 $93.7 Million
Q2 2022 Aug 10, 2022	SELL	$71.48 - $86.85 $12 Million - $14.6 Million	-167,979 Reduced 5.87%	2,693,524 $223 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $200 Million - $250 Million	2,697,524 Added 1645.04%	2,861,503 $221 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $9.58 Million - $12.2 Million	-133,514 Reduced 44.88%	163,979 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $11.5 Million - $13.1 Million	153,667 Added 106.84%	297,493 $23 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $3.89 Million - $4.37 Million	-51,512 Reduced 26.37%	143,826 $12 Million
Q1 2021 May 12, 2021	BUY	$74.73 - $90.69 $4.88 Million - $5.92 Million	65,250 Added 50.16%	195,338 $14.8 Million
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $3.31 Million - $4.12 Million	45,648 Added 54.06%	130,088 $11.4 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $2.89 Million - $5.27 Million	-40,207 Reduced 32.26%	84,440 $6.42 Million
Q2 2020 Jul 31, 2020	BUY	$79.55 - $124.22 $530,916 - $829,044	6,674 Added 5.66%	124,647 $15.4 Million
Q1 2020 May 01, 2020	SELL	$71.37 - $96.85 $1.88 Million - $2.55 Million	-26,296 Reduced 18.23%	117,973 $9.97 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $9.89 Million - $13.3 Million	-153,846 Reduced 51.61%	144,269 $12.2 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $10.1 Million - $12.7 Million	149,236 Added 100.24%	298,115 $20.1 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $1.55 Million - $1.82 Million	-19,346 Reduced 11.5%	148,879 $12.8 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $762,346 - $892,905	9,054 Added 5.69%	168,225 $14.9 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $933,550 - $1.24 Million	-11,649 Reduced 6.82%	159,171 $13.6 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $5.21 Million - $5.86 Million	55,475 Added 48.09%	170,820 $16.6 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $9.82 Million - $12.8 Million	-129,186 Reduced 52.83%	115,345 $10.9 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $4.98 Million - $5.94 Million	64,143 Added 35.56%	244,531 $19.8 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $2 Million - $2.36 Million	24,825 Added 15.96%	180,388 $16.1 Million
Q3 2017 Nov 14, 2017	SELL	$80.6 - $94.95 $1.97 Million - $2.32 Million	-24,469 Reduced 13.59%	155,563 $14.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,636 Added 12.95%	180,032 $16.4 Million
Q1 2017 Nov 14, 2017	BUY	N/A	159,396	159,396 $14 Million

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

185M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account